Centers

test

Experimental Pharmacology Laboratory

EU-OPENSCREEN

sfgd

Read more
The University of Cyprus Experimental Pharmacology Laboratory is a molecular and behavioural pharmacology laboratory based in the Medical School of the University of Cyprus.
Our research revolves around novel drug discovery and drug repurposing...
Read more
EU-OPENSCREEN is a multinational, not-for-profit initiative, which integrates high-capacity screening platforms and chemistry groups across Europe. The aim of this initiative is to support individual scientists interested in chemical biology...
Read more

Partnerships

Events

Jobs

Johns Hopkins BSi Licenses GCPII Assets from Eisai

Johns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted...

 
View all

GSK and Yale to partner on drug discovery development

GlaxoSmithKline (GSK) and Yale University will partner to design a new class of molecules to target disease-causing proteins. This is the latest in a string of deals between Yale’s academic researchers and global pharmaceutical companies.

 
View all

Sanofi and Stanford's Bio-X to Collaborate on Early Stage Research

Sanofi and Stanford University's Bio-X have entered into a multi-year collaboration that support interdisciplinary collaborative research to be conducted at Stanford. A joint steering committee comprising of representatives from Stanford and...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All